Curated News
By: NewsRamp Editorial Staff
May 21, 2026

MindBio Therapeutics Expands AI Voice Platform to Detect Fatigue in Workplaces

Discuss on Substack
Original Source

TLDR

  • MindBio Therapeutics adds fatigue detection to its AI voice platform, offering a non-invasive advantage over traditional drug and alcohol testing in industrial workplaces.
  • MindBio's AI voice analytics platform detects fatigue and impairment via speech patterns, with kiosk testing on track for late Q2 2026.
  • MindBio's fatigue detection technology enhances workplace safety by non-invasively monitoring impairment, making high-risk environments safer for workers.
  • MindBio's AI voice kiosks can detect fatigue and drugs without breath, saliva, or blood samples, using only speech.

Impact - Why it Matters

Workplace fatigue is a leading cause of accidents in industries like mining, aviation, and construction, often leading to injuries, fatalities, and financial losses. MindBio's fatigue detection technology offers a non-invasive, real-time screening solution that can alert employers before a fatigued worker operates heavy machinery or performs safety-critical tasks. This innovation could significantly reduce workplace incidents, improve employee well-being, and lower costs associated with accidents and downtime. By integrating fatigue detection into their existing impairment screening kiosks, MindBio provides a comprehensive safety tool that addresses multiple risk factors, potentially setting a new standard for occupational health monitoring.

Summary

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company specializing in AI-driven voice analytics, is broadening its platform to include fatigue detection alongside its existing drug and alcohol impairment screening. The company announced on May 11 that it has developed a fatigue prediction model using speech analytics and proprietary artificial intelligence, and has filed a patent application covering the detection of neurologically active substances and fatigue through voice analysis. This new module will be integrated into MindBio's planned Edge AI Intoxication Detection Kiosks, which are being designed for high-risk industrial workplaces such as mining, aviation, transportation, and construction. The kiosks aim to provide a non-invasive alternative to traditional breath, saliva, blood, and laboratory-based testing systems.

Management confirmed that commercial testing of the kiosk hardware and software remains on track for late Q2 2026. The fatigue detection capability is expected to enhance workplace safety by identifying signs of fatigue, which is a major contributor to accidents in safety-sensitive industries. MindBio's technology analyzes voice patterns to detect impairments, offering a quick and non-invasive method for screening employees before they engage in tasks that require alertness. The company's expansion into fatigue detection underscores its commitment to addressing broader occupational health and safety challenges.

MindBio's announcement was disseminated through InvestorWire, a specialized communications platform that is part of the IBN Dynamic Brand Portfolio. InvestorWire provides advanced wire-grade press release syndication and editorial syndication to over 5,000 outlets, helping companies reach a wide audience of investors and the general public. The full news release is available at https://ibn.fm/4KNzG, and updates on MBQIF can be found at https://ibn.fm/MBQIF.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, MindBio Therapeutics Expands AI Voice Platform to Detect Fatigue in Workplaces

blockchain registration record for this content.